Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
life sciences
medicare
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
aduro biotech
alzheimer's disease
biotech
cancer
cancer immunotherapy
deals
drug prices
johnson & johnson
medicaid
novartis
startups
What
drug
price
3
×
bio
companies
roundup
administration
alzheimer’s
angry
anti
approval
benefited
biogen’s
biopharmaceutical
convo
despite
different
earlier
fail
failures
fear
gene
increases
industry
latest
littered
losing
nash
new
news
pharma
pharmaceutical
plan
plans
prescription
presidential
prices
raise
remains
rhetoric
road
Language
Current search:
price
×
biogen
×
@xconomy.com
4 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
